Clinical Trials Directory

Trials / Completed

CompletedNCT03461068

Exogenous Ketones and Glucose Tolerance

The Effect of Exogenous Ketone Monoester Supplement on Glycemic Response to an Oral Glucose Tolerance Test

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The ketone body beta-hydroxybutyrate is produced during prolonged fasting or when endogenous carbohydrate stores are depleted and can be used as an alternative fuel source. Exogenous beta-hydroxybutyrate, in the form of a ketone monoester, is proposed to have glucose-lowering potential but this has not been adequately studied. The purpose of this study is to determine whether supplementing with an acute dose of ketone monoester can improve the glycemic response to an oral glucose tolerance test in individuals with impaired fasting glucose.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKetone monoesterAcute ingestion of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate prior a 2-hour oral glucose tolerance test.
DIETARY_SUPPLEMENTPlaceboAcute ingestion of a taste-matched placebo prior a 2-hour oral glucose tolerance test.

Timeline

Start date
2018-03-26
Primary completion
2018-10-03
Completion
2018-10-15
First posted
2018-03-09
Last updated
2019-04-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03461068. Inclusion in this directory is not an endorsement.